SOSheila B. Ogoma

Sheila B. Ogoma

*This is an algorithmically generated author record based on publicly available information.

Sheila B. Ogoma has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • April Monroe

    Johns Hopkins Center for Communication Programs, PMI VectorWorks Project, Baltimore, USA

    1 shared publication
  • Arnold S. Mmando

    Ifakara Health Institute, Environmental Health and Ecological Sciences Thematic Group, Coordination Office, Dar es Salaam, United Republic of Tanzania

    1 shared publication
  • David Malone

    Innovative Vector Control Consortium, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

    1 shared publication
  • Fredros Oketch Okumu

    Environmental Health and Ecological Sciences Department, Ifakara Health Institute, Morogoro, United Republic of Tanzania

    1 shared publication
  • Gerry F. Killeen

    Ifakara Health Institute, Environmental Health and Ecological Sciences Thematic Group, Coordination Office, Dar es Salaam, United Republic of Tanzania

    1 shared publication
  • Ilinca Ioana Ciubotariu

    Department of Biological Sciences, Purdue University , 915 Mitch Daniels Blvd., West Lafayette, IN 47907-2054

    1 shared publication

Latest Publications

  • Ifakara MasterClasses: lessons from leading experts on the battle against malaria

    by Ilinca I. Ciubotariu, April Monroe, Nana Aba Williams, Sheila B. Ogoma, Fredros Okumu


  • Open Access

    A low technology emanator treated with the volatile pyrethroid transfluthrin confers long term protection against outdoor biting vectors of lymphatic filariasis, arboviruses and malaria

    by Sheila B. Ogoma, Arnold S. Mmando, Johnson K. Swai, Sebastian Horstmann, David Malone, Gerry F. Killeen

    The vapor phase of the volatile pyrethroid transfluthrin incapacitates mosquitoes and prevents them from feeding. Although existing emanator products for delivering volatile pyrethroids protect against outdoor mosquito bites, they are too short-lived to be practical or affordable for routine use in low-income settings. New transfluthrin emanators, comprised simply of treated hessian fabric strips, have recently proven highly protective against outdoor-biting vectors of lymphatic filariasis, arboviruses and malaria, but their full protective lifespan, minimum dose requirements, and range of protection have not previously been assessed. The effects of transfluthrin-treated hessian strips upon mosquito biting exposure of users and nearby non-users, as well as dependence of protection upon treatment dose, were measured outdoors in rural Tanzania using human landing catches (HLC). Strips treated with 10ml of transfluthrin prevented at least three quarters (p < 0.001) of outdoor bites by Anopheles arabiensis, Culex spp. and Mansonia spp. mosquitoes, and >90% protection against bites on warmer nights with higher evaporation rates, for at least one year. Strips treated with this high dose also reduced biting exposure of non-users at a distance of up to 5m from the strips for An. arabiensis (p < 0.001) and up to 2m for Mansonia spp. (p = 0.008), but provided no protection to non-users against Culex spp. No evidence of increased risk for non-users, caused by diversion of mosquitoes to unprotected individuals, was found at any distance within an 80m radius. A dose of only 1ml provided equivalent protection to the 10ml dose against An. arabiensis, Culex spp. and Mansonia spp. mosquitoes over 6 months (p < 0.001). Transfluthrin-treated hessian emanators provide safe, affordable, long-term protection against several different pathogen-transmitting mosquito taxa that attack humans outdoors, where they are usually active and cannot be protected by bed nets or residual sprays with conventional, solid-phase insecticides. Many vector-borne parasites and arboviruses are transmitted by outdoor-biting mosquitoes, especially in the evenings and mornings, often despite high coverage of houses with insecticidal nets and residual sprays. The goal of the study was to measure the long-term durability of protection provided by a new, low-technology, passive emanator for the volatile pyrethroid transfluthrin against outdoor-biting mosquitoes. Treated hessian strips reduced exposure of users to three different types of vector mosquitoes by more than three quarters over the first year after treatment, and prevented more than 90% of bites on warmer nights when the active ingredient evaporated faster. Treated strips protected non-users against some vector mosquito species, as far away as 5m from the strip. Reassuringly, mosquitoes were not diverted to nearby unprotected individuals anywhere within an 80m radius. Transfluthrin-treated hessian strips may have considerable potential for integrated control of multiple vectors of filariasis, arboviruses and malaria, which are co-endemic in many tropical areas.